These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Natural history of multiple sclerosis: a unifying concept. Confavreux C, Vukusic S. Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308 [Abstract] [Full Text] [Related]
3. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS. Neurology; 2007 Oct 09; 69(15):1498-507. PubMed ID: 17699802 [Abstract] [Full Text] [Related]
4. Relapses and progression of disability in multiple sclerosis. Confavreux C, Vukusic S, Moreau T, Adeleine P. N Engl J Med; 2000 Nov 16; 343(20):1430-8. PubMed ID: 11078767 [Abstract] [Full Text] [Related]
5. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy. Skoog B, Runmarker B, Winblad S, Ekholm S, Andersen O. Brain; 2012 Mar 16; 135(Pt 3):900-11. PubMed ID: 22366800 [Abstract] [Full Text] [Related]
10. Demographics and clinical characteristics of multiple sclerosis in Kuwait. Alroughani R, Ahmed SF, Al-Hashel J. Eur Neurol; 2014 Mar 16; 72(3-4):181-5. PubMed ID: 25227152 [Abstract] [Full Text] [Related]
11. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G, Italian Devic's Study Group (IDESG). J Neurol; 2004 Jan 16; 251(1):47-52. PubMed ID: 14999489 [Abstract] [Full Text] [Related]
13. [Prognostics factors of renal failure in multiple sclerosis]. Viart L, Elalouf V, Petit J, Al Khedr A, Kristkowiak P, Saint F. Prog Urol; 2012 Dec 16; 22(16):1026-32. PubMed ID: 23178100 [Abstract] [Full Text] [Related]
14. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience. Pozzilli C, Prosperini L, Sbardella E, De Giglio L, Onesti E, Tomassini V. Neurol Sci; 2005 Dec 16; 26 Suppl 4():S174-8. PubMed ID: 16388353 [Abstract] [Full Text] [Related]
15. Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis. Alroughani R, Ahmed SF, Al-Hashel J. Pediatr Neurol; 2015 Dec 16; 53(6):508-12. PubMed ID: 26383244 [Abstract] [Full Text] [Related]
19. The clinical course of multiple sclerosis patients in Hong Kong. Lau KK, Wong WW, Sheng B, Yu IT, Fung BH, Li HL, Ma KF, Wong LK, Li PC. J Neurol Sci; 2008 May 15; 268(1-2):78-82. PubMed ID: 18068191 [Abstract] [Full Text] [Related]
20. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. Tavazzi E, Dwyer MG, Weinstock-Guttman B, Lema J, Bastianello S, Bergamaschi R, Cosi V, Benedict RH, Munschauer FE, Zivadinov R. Neuroimage; 2007 Jul 01; 36(3):746-54. PubMed ID: 17498974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]